Signal transduction pathways of calcitonin/calcitonin receptor regulating cytoskeletal organization and bone-resorbing activity of osteoclasts

Cellular and Molecular Biology

Volumn 52, Issue 3, 2006, Pages 19-23

  Tanaka, S ^a,d   Suzuki, H ^b   Yamauchi, H ^b   Nakamura, I ^c   Nakamura, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b ASAHI CHEMICAL INDUSTRY CO   (Japan)

^c Yugawara Kosei Nenkin Hospital   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BETA TUBULIN; CALCITONIN; CALCITONIN RECEPTOR; CALCITRIOL; COLONY STIMULATING FACTOR 1; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; F ACTIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN KINASE C; PROTON PUMP;

CELL CULTURE; CELL VACUOLE; CYTOSKELETON; DOWN REGULATION; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; METABOLIC BONE DISEASE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PAGET BONE DISEASE; PH; REVIEW; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY;

ANIMALS; BONE RESORPTION; CALCITONIN; CYTOSKELETON; OSTEOCLASTS; RECEPTORS, CALCITONIN; SIGNAL TRANSDUCTION;

EID: 33746594952     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Abu-Amer Y, Ross FP, Schlesinger P, Tondravi MM, Teitelbaum SL, Substrate recognition by osteoclast precursors induces C-src/microtubule association. J Cell Biol 1997, 137:247-58.
2. Baron R, Polarity and membrane transport in osteoclasts. Connect Tissue Res 1989, 20:109-20.
3. Barrientos A, Barros MH, Valnot I, Rotig A, Rustin P, Tzagoloff A, Cytochrome oxidase in health and disease. Gene 2002, 286:53-63.
4. Blair HC, Robinson LJ, Zaidi M, Osteoclast signalling pathways. Biochem Biophys Res Commun 2005, 328:728-38.
5. Boyle WJ, Simonet WS, Lacey DL, Osteoclast differentiation and activation. Nature 2003, 423: 337-42.
6. Chambers TJ, Magnus CJ, Calcitonin alters behaviour of isolated osteoclasts. J Pathol 1982, 136: 27-39.
7. Chambers TJ, McSheehy PM, Thomson BM, Fuller K, The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology 1985, 116:234-9.
8. Chen Y, Shyu JF, Santhanagopal A, Inoue D, David JP, Dixon SJ, Horne WC, Baron R, The calcitonin receptor stimulates Shc tyrosine phosphorylation and Erk1/2 activation. Involvement of Gi, protein kinase C, and calcium. J Biol Chem 1998, 273:19809-16.
9. Chesnut CH, 3rd, Silverman S, Andriano K, Genant H, Gimona A, Harris S, Kiel D, LeBoff M, Maricic M, Miller P, Moniz C, Peacock M, Richardson P, Watts N, Baylink D, A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med 2000, 109:267-76.
10. Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C, Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 2002, 23:570-8.
11. Destaing O, Saltel F, Geminard JC, Jurdic P, Bard F, Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol Biol Cell 2003, 14:407-16.
12. Eriksen EF, Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocr Rev 1986, 7:379-408.
13. Friedman J, Raisz LG, Thyrocalcitonin: inhibitor of bone resorption in tissue culture. Science 1965, 150:1465-7.
14. Hosking DJ, Vennart W, Huddlestone LB, Bone turnover in Paget's disease: biochemical and kinetic measurements during salmon calcitonin therapy. Calcif Tissue Int 1981, 33:471-6.
15. Lin HY, Harris TL, Flannery MS, Aruffo A, Kaji EH, Gorn A, Kolakowski LF, Jr., Lodish HF, Goldring SR, Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 1991, 254:1022-4.
16. Miyazaki T, Neff L, Tanaka S, Horne WC, Baron R, Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J Cell Biol 2003, 160:709-18.
17. Nicholson GC, Moseley JM, Sexton PM, Martin TJ, Chicken osteoclasts do not possess calcitonin receptors. J Bone Miner Res 1987, 2:53-9.
18. Orimo H, [Recent progress in osteoporosis research]. Nippon Ronen Igakkai Zasshi 2005, 42:18-20.
19. Overgaard K, Hansen MA, Jensen SB, Christiansen C, Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. Bmj 1992, 305:556-61.
20. Parfitt AM, Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 1994, 55:273-86.
21. Pondel M, Calcitonin and calcitonin receptors: bone and beyond. Int J Exp Pathol 2000, 81:405-22.
22. Raisz LG, Niemann I, Early effects of parathyroid hormone and thyrocalcitonin on bone in organ culture. Nature 1967, 214:486-7.
23. Raisz LG, Seeman E, Causes of age-related bone loss and bone fragility: an alternative view. J Bone Miner Res 2001, 16:1948-52.
24. Seeman E, Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int 2003, 14 Suppl 3:S2-8.
25. Su Y, Chakraborty M, Nathanson MH, Baron R, Differential effects of the 3′,5′-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitonin. Endocrinology 1992, 131:1497-502.
26. Suda T, Nakamura I, Jimi E, Takahashi N, Regulation of osteoclast function. J Bone Miner Res 1997, 12:869-79.
27. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ, Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999, 20:345-57.
28. Suzuki H, Nakamura I, Takahashi N, Ikuhara T, Matsuzaki K, Isogai Y, Hori M, Suda T, Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts. Endocrinology 1996, 137:4685-90.
29. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T, Osteoblastic cells are involved in osteoclast formation. Endocrinology 1988, 123:2600-2.
30. Tanaka S, Nakamura I, Inoue J, Oda H, Nakamura K, Signal transduction pathways regulating osteoclast differentiation and function. J Bone Miner Metab 2003, 21:123-33.
31. Yamauchi H, Suzuki H, Orimo H, Calcitonin for the treatment of osteoporosis: dosage and dosing interval in Japan. J Bone Miner Metab 2003, 21:198-204.